Top Stories
-
The three scientists honored by the 2019 Horwitz Prize played key roles in identifying and deciphering the PI3K pathway, which has led to new treatments for several types of cancer.
-
By learning how contagious cancer spreads among shellfish, scientists hope to better understand how cancer metastasizes in people.
-
Researchers at Columbia are tackling cancer disparities in northern Manhattan and surrounding areas through the National Cancer Institute’s network of community-based research programs.
-
Columbia oncologists are bringing their latest techniques in precision medicine to veterans with advanced prostate cancer.
Latest News
- July 11, 2014
In preclinical tests, a two-drug combination that blocks cancer’s escape route shows promise against MPNST, an aggressive nerve tumor.
Topic
- July 9, 2014
The new 2014 Irving Scholars are Siddhartha Mukherjee, Carolyn Rodriguez, Bret Rutherford, and Anne-Catrin Uhlemann.
Topic
- July 3, 2014
New technology allows scientists to dive into the inner world of cells in everything from cancers to mummies. Learn more at lab’s open house on July 10.
Topic
- June 25, 2014
Several drugs in development for pancreatic cancer dissolve the dense tissue that surrounds and protects the tumors, but new research shows why some may not work.
Topic
- June 19, 2014
For the first time, a therapy has been found that can delay progression of metastatic uveal melanoma, a rare and deadly form of melanoma of the eye.
Topic
-
Source:
MedPage TodayJune 9, 2014Topic
- May 16, 2014
People diagnosed with celiac disease are not at increased risk of melanoma, researchers at CUMC and Karolinska Institutet have found.
Topic
- May 12, 2014
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
Topic
- April 18, 2014
New bone marrow transplant unit specializes in cutting-edge treatments for blood cancers and autoimmune diseases.
Topic
- April 9, 2014
Important tips on sunglasses and sun exposure from NewYork-Presbyterian Hospital experts.
Topic
